Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Verhamme

Showing results (1-10 of 359) with videos related to

Pageof 36
Sort By:
European Heart Journal|October 27, 2023
The science and art of predicting recurrent VTEMarc Carrier, Peter Verhamme
Thrombosis and Haemostasis|January 25, 2020
The Dangerous Liaisons between Chronic Obstructive Pulmonary Disease and Venous ThromboembolismJob Harenberg, Peter Verhamme
Advances in Therapy|June 29, 2013
Rivaroxaban for the treatment of pulmonary embolismThomas Vanassche, Peter Verhamme
Clinical Toxicology (Philadelphia, Pa.)|October 15, 2016
Answer by the authors to the letter of Dr. Wang and colleagues, concerning our case report entitled "Idarucizumab for dabigatran overdose"Marijke Peetermans, Peter Verhamme
Acta Cardiologica|June 1, 2007
A new era for oral anticoagulation? Old and new anticoagulant drugsPeter Verhamme, Raymond Verhaeghe
Circulation|December 18, 2013
Direct oral anticoagulants for acute venous thromboembolism: closing the circle?Peter Verhamme, Henri Bounameaux
Acta Cardiologica|December 4, 2010
Dabigatran for stroke prevention in atrial fibrillation: from RE-LY to daily clinical practiceHein Heidbuchel, Peter Verhamme
European Heart Journal|September 25, 2007
Improving the quality of anticoagulant therapy in patients with mechanical heart valves: what are we waiting for?Paul Herijgers, Peter Verhamme
Acta Cardiologica|November 6, 2013
Organizing patient-centred anticoagulant therapyPeter Verhamme, Hein Heidbuchel
Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology|April 12, 2008
Keeping your vascular integrity: What can we learn from fish?Aernout Luttun, Peter Verhamme
Pageof 36

Showing results (1-10 of 359) with videos related to

Sort By:
Pageof 36
European Heart Journal|October 27, 2023
The science and art of predicting recurrent VTEMarc Carrier, Peter Verhamme
Thrombosis and Haemostasis|January 25, 2020
The Dangerous Liaisons between Chronic Obstructive Pulmonary Disease and Venous ThromboembolismJob Harenberg, Peter Verhamme
Advances in Therapy|June 29, 2013
Rivaroxaban for the treatment of pulmonary embolismThomas Vanassche, Peter Verhamme
Clinical Toxicology (Philadelphia, Pa.)|October 15, 2016
Answer by the authors to the letter of Dr. Wang and colleagues, concerning our case report entitled "Idarucizumab for dabigatran overdose"Marijke Peetermans, Peter Verhamme
Acta Cardiologica|June 1, 2007
A new era for oral anticoagulation? Old and new anticoagulant drugsPeter Verhamme, Raymond Verhaeghe
Circulation|December 18, 2013
Direct oral anticoagulants for acute venous thromboembolism: closing the circle?Peter Verhamme, Henri Bounameaux
Acta Cardiologica|December 4, 2010
Dabigatran for stroke prevention in atrial fibrillation: from RE-LY to daily clinical practiceHein Heidbuchel, Peter Verhamme
European Heart Journal|September 25, 2007
Improving the quality of anticoagulant therapy in patients with mechanical heart valves: what are we waiting for?Paul Herijgers, Peter Verhamme
Acta Cardiologica|November 6, 2013
Organizing patient-centred anticoagulant therapyPeter Verhamme, Hein Heidbuchel
Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology|April 12, 2008
Keeping your vascular integrity: What can we learn from fish?Aernout Luttun, Peter Verhamme
Pageof 36